ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.

Jena D French et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.